Healthcare GI Partners Launches Rose BioRose BioSolutions is an independent company focused on cell and gene therapy manufacturing and development services. May 8, 2026
Healthcare Amgen Bolsters Oncology Pipeline with Acquisition of Dark Blue TherapeuticsDark Blue Therapeutics specializes in first-in-class small molecule targeted protein degraders designed to treat cancer. January 6, 2026
Healthcare Eli Lilly Buys Adverum Biotechnologies for Up to $12.47 Per ShareAdverum Biotechnologies is a clinical-stage gene therapy firm focused on ocular diseases. October 24, 2025
Healthcare Carlyle, SK Capital Raise Offer for bluebird bioThe biotech firm has struggled with financial instability for years and recently laid off 25 percent of its workforce. May 15, 2025
Healthcare Bluebird bio Reaffirms Carlyle Deal After Ayrmid Bid FailsThis marks the second time Ayrmid has engaged with Bluebird without delivering a definitive proposal. April 17, 2025